Safety, tolerability, and efficacy outcomes of the Investigation of Levetiracetam in Alzheimer's disease (ILiAD) study: a pilot, double‐blind placebo‐controlled crossover trial

Abstract Objective To assess whether the antiseizure medication levetiracetam may improve cognition in individuals with Alzheimer's disease who have not previously experienced a seizure. Methods We performed a randomized, double‐blind, placebo‐controlled crossover pilot study in individuals with mil...

Description complète

Détails bibliographiques

Auteurs principaux:	Arjune Sen, Sofia Toniolo, Xin You Tai, Mary Akinola, Mkael Symmonds, Sergio Mura, Joanne Galloway, Angela Hallam, Jane Y. C. Chan, Ivan Koychev, Chris Butler, John Geddes, Gabriel Davis Jones, Younes Tabi, Raquel Maio, Eleni Frangou, Sharon Love, Sian Thompson, Rohan Van Der Putt, Sanjay G. Manohar, Rupert McShane, Masud Husain
Format:	Artigo
Langue:	Inglês
Publié:	Wiley 2024-12-01
Collection:	Epilepsia Open
Sujets:	antiseizure medications dementia epilepsy Oxford Memory Test seizure
Accès en ligne:	https://doi.org/10.1002/epi4.13070
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!